$80K - $100K(Ladders Estimates)
Austin, TX 78701
Industry: Education, Government & Non-Profit•
Not Specified years
Posted 57 days ago
Research training and experience as evidenced by research publications, principal or co-principal investigator on multiple grants from federal agencies or equivalent bodies, demonstrated successful mentorship of post-doctoral fellows and/or residents and faculty. Passion for and commitment to cancer research as a means to improve human health is necessary. A terminal/advanced professional degree in a relevant field is required.
The successful candidate will bring a strong record of leadership within the cancer research realm as well as international stature.
Knowledge, Skills and Abilities
A passionate visionary leader with a proven track record of managing an organization through transition and growth
Exceptional strategic thinking ability and demonstrated success in innovation, planning and implementation
Outstanding skills and proven success in securing research support from the full range of sources, including federal funding agencies, private foundations and philanthropy
Proven financial and organizational management skills; track record in the oversight of financial, legal and business operations; demonstrated strengths in workforce management
Knowledge of new and innovative models of collaboration and outreach; strong ethical values
Possesses a network of strong relationships with international leaders in cancer research community
Ability to effectively function as part of a team, and in collaboration with diverse audiences
The University of Minnesota is a top ten public research university with externally funded research programs of more than $900 million. The Hormel Institute was established in Austin, Minnesota in 1942 in an agreement between the Regents of the University of Minnesota and the Hormel Foundation. Reporting to the University's Office of the Vice President for Research, the Institute has strong ties to other units of the University, and research collaborations with the Mayo Clinic and Hormel Foods Inc., all of which allow it to serve as a convener, catalyst, and entrepreneurial space for cutting-edge research and engagement. The Institute, which is an integral part of the University of Minnesota's Masonic Cancer Center, focuses on the discovery of better ways to prevent, detect, and treat cancer, especially with respect to determining cancer's basic molecular mechanisms in order to develop new anti-cancer agents. In the process, the Institute develops the next generation of global cancer-research leaders and builds world-changing partnerships. With a recently expanded campus and extraordinary infrastructure, including high-performance computing and a Titan Krios cryo-electron microscope, the Institute comprises an established community of scholars which is positioned to grow and excel.
The Executive Director provides strategic vision and support for The Hormel Institute programs, and leads efforts to promote collaboration across the University of Minnesota and with its key partners. S/he will be an established leader who will bring a robust cancer research program to the Institute, and will in addition enhance and diversify the revenue stream of the Institute with particular emphasis on philanthropic and extramural research support to enable its activities. The Executive Director will be the principal spokesperson for the Institute and will represent it in a variety of settings, both internal and external to the University.
This is a full time faculty appointment at a rank commensurate with experience and academic achievement of the selected candidate for the position. The Director will be tenured with approval from an appropriate program and will report to and advise the Vice President for Research.
Provide Strategic and Visionary Leadership for the Institute
Build Research Capacity
Serve as a Unifying and Decisive University Leader
Build Philanthropic Support
Build upon the Hormel Institute's Strong Reputation
Develop and Commercialize Intellectual Property
Translational and Clinical Research
Valid Through: 2019-9-16